Cost‐effectiveness analysis of pembrolizumab plus...

  • Main
  • 2020 / 01
  • Cost‐effectiveness analysis of pembrolizumab plus...

Cost‐effectiveness analysis of pembrolizumab plus chemotherapy with PD‐L1 test for the first‐line treatment of NSCLC

Wan, Ning, Zhang, Tian‐tian, Hua, Si‐hua, Lu, Zi‐luo, Ji, Bo, Li, Li‐xia, Lu, Li‐qing, Huang, Wen‐jie, Jiang, Jie, Li, Jian
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Cancer Medicine
DOI:
10.1002/cam4.2793
Date:
January, 2020
File:
PDF, 1003 KB
english, 2020
Conversion to is in progress
Conversion to is failed